Squarepoint Ops LLC

Position in ANIK — Anika Therapeutics, Inc.

CIK 1642575 NEW YORK, NY

Position in ANIK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$274,327

+$62,668 QoQ

Shares Held

18,751

+45.8% QoQ

Ownership

0.140%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#67

of 134 holders

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $151,394,819 across 40 Drug Manufacturers - Specialty & Generic names. ANIK ranks #30 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	633,370	$45,513,968
2	UTHR	UNITED THERAPEUTICS Corp	48,656	$26,363,280
3	HIMS	Hims & Hers Health, Inc.	617,308	$21,402,068
4	KNSA	Kiniksa Pharmaceuticals International, plc	140,059	$8,956,773
5	NBIX	Neurocrine Biosciences Inc	44,143	$7,439,861
6	ALKS	Alkermes plc.	115,195	$6,036,218
7	ELAN	Elanco Animal Health Inc	133,225	$3,278,667
8	HROW	Harrow, Inc.	73,622	$3,126,726

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$274,327	18,751	+45.8%	Shares	Defined	2026-08-14
2024-12-31	$211,659	12,859	-40.6%	Shares	Defined	2025-02-14
2024-06-30	$548,343	21,648	-58.7%	Shares	Defined	2024-08-14
2024-03-31	$1,332,407	52,457	-10.4%	Shares	Defined	2024-05-15
2023-12-31	$1,326,856	58,555	+196.9%	Shares	Defined	2024-02-14
2023-09-30	$367,383	19,720	+2.2%	Shares	Defined	2023-11-14
2022-03-31	$484,321	19,288	+292.0%	Shares	Defined	2022-05-16
2021-09-30	$209,437	4,921	-58.8%	Shares	Defined	2021-11-15
2021-06-30	$516,709	11,936	+103.6%	Shares	Defined	2021-08-16
2021-03-31	$239,110	5,862	+9.1%	Shares	Defined	2021-05-17
2020-12-31	$243,181	5,373	—	Shares	Defined	2021-02-16
No filing history on record for this holder in this stock.